EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1

Alina Malyutina iD, Carina Lund iD, Saara Tegelberg iD, Paula Hakala, Tuula A Nyman iD, Anna-Elina Lehesjoki iD, Tarja Joensuu iD

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Alina Malyutina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Folkhälsan Research Center, 00290 Helsinki, Finland. Hauptthemen laut MEDLINE: Proteomics, Transcriptome, Proteome, Myoclonic Epilepsies, Progressive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Folkhalsanin Tutkimussaati, Sigrid Juseliuksen Saati, Finska Lakaresallskapet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive myoclonus epilepsy type 1 (EPM1) is a rare neurodegenerative disease caused by partial loss of function of cystatin B (CSTB), a cysteine protease inhibitor with known neuroprotective roles. The disease mechanisms remain largely unsolved, and no treatments are available to control the debilitating myoclonus in EPM1. We investigated the impact of CSTB loss on transcriptome and proteome in three regions of CSTB-deficient (Cstb−/−) mouse brain – the cerebellum, cerebral cortex and hippocampus – during disease progression, providing comprehensive insights into the molecular changes and disease mechanisms. We elucidated three critical pathways as potential therapeutic targets. First, significant upregulation of immune response genes indicates heightened immune activity across all brain regions. Second, consistent downregulation of the oxidative phosphorylation pathway with differential expression of mitochondrial genes implies impaired energy metabolism primarily affecting the cerebellum. Third, upregulation of genes essential for lysosomal function with simultaneous downregulation of genes encoding proteins crucial for lysosomal acidification suggests lysosomal dysfunction as an essential pathogenetic mechanism. By combining proteome with transcriptome data, we identified clusterin, apolipoprotein E, peroxiredoxin 6, cathepsin D and aldolase C as potential biomarkers for disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsTranscriptomeProteomeMyoclonic Epilepsies, ProgressiveAnimalsCystatin BLysosomesGene Expression RegulationMitochondriaGene Expression ProfilingBiomarkersCerebellumBrain

Stichwörter der Autor:innen

Cstb−/− mouseBrainCystatin BEPM1ProteomicsTranscriptomics

Substanzen

Cystatin BProteomeBiomarkersCstb protein, mouse

Autor:innen und Institutionen

  • Folkhälsan Research Center, 00290 Helsinki, Finland.
  • Orion Corporation, 02200 Espoo, Finland.
  • Medicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.

ORCID-Profile: Alina Malyutina, Carina Lund, Saara Tegelberg, Tuula A Nyman, Anna-Elina Lehesjoki, Tarja Joensuu

Förderung

  • Folkhalsanin Tutkimussaati
  • Sigrid Juseliuksen Saati
  • Finska Lakaresallskapet
  • Medicinska Understadsfareningen Liv och Halsa
  • Norges Forskningsrad
  • Folkhälsanin Tutkimussäätiö
  • Business Finland
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Malyutina, A., Lund, C., Tegelberg, S., Hakala, P., Nyman, T. A., Lehesjoki, A. E., & Joensuu, T. (2026). Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052681

Vancouver

Malyutina A, Lund C, Tegelberg S, Hakala P, Nyman TA, Lehesjoki AE, et al. Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052681

BibTeX
@article{Malyutina2026,
  author = {Malyutina, Alina and Lund, Carina and Tegelberg, Saara and Hakala, Paula and Nyman, Tuula A and Lehesjoki, Anna-Elina and Joensuu, Tarja},
  title = {Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052681}
}
Kostenlos starten →